Biogen Revenue Down as Multiple Sclerosis Sales Slide

Date:




Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Hot and dry conditions persist into the workweek

Hot and mostly dry weather will be in place...

Ella Langley Says She Leans On God, Not ‘Men or Drugs’

Ella Langley says that she has learned to rely...